Search research articles
Contact Us
Filters
Showing results (51-60 of 251) with videos related to
Page
of 26
Sort By:
Frontiers in Oncology
|
April 4, 2019
Novel Approaches to Improve the Efficacy of Immuno-Radiotherapy
Maxim Shevtsov, Hiro Sato, Gabriele Multhoff, et al.
Cell Stress & Chaperones
|
August 31, 2012
Radiosensitization of wildtype p53 cancer cells by the MDM2-inhibitor PXN727 is associated with altered heat shock protein 70 (Hsp70) levels
Daniela Schilling, Michael Düwel, Michael Molls, et al.
Biological Chemistry
|
April 5, 2003
Interaction of heat shock protein 70 peptide with NK cells involves the NK receptor CD94
Catharina Gross, Daniel Hansch, Robert Gastpar, et al.
Journal of Immunological Methods
|
August 2, 2005
Nucleofection of non-B cells with mini-Epstein-Barr virus DNA
Jürgen Radons, Catharina Gross, Stefan Stangl, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 4, 2006
Control of metastasized pancreatic carcinomas in SCID/beige mice with human IL-2/TKD-activated NK cells
Stefan Stangl, Andreas Wortmann, Ulrich Guertler, et al.
Cell Stress & Chaperones
|
March 19, 2008
The therapeutic implications of clinically applied modifiers of heat shock protein 70 (Hsp70) expression by tumor cells
Mathias Gehrmann, Jürgen Radons, Michael Molls, et al.
Cell Stress & Chaperones
|
April 10, 2009
The atheroprotective properties of Hsp70: a role for Hsp70-endothelial interactions?
A Graham Pockley, Stuart K Calderwood, Gabriele Multhoff
Cancer Letters
|
January 22, 2017
The Hsp70 inhibiting peptide aptamer A17 potentiates radiosensitization of tumor cells by Hsp90 inhibition
Daniela Schilling, Carmen Garrido, Stephanie E Combs, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 24, 2005
Alternative mechanism by which IFN-gamma enhances tumor recognition: active release of heat shock protein 72
Maria A Bausero, Robert Gastpar, Gabriele Multhoff, et al.
Cancer Immunology, Immunotherapy : CII
|
April 10, 2015
NZ28-induced inhibition of HSF1, SP1 and NF-κB triggers the loss of the natural killer cell-activating ligands MICA/B on human tumor cells
Daniela Schilling, Annett Kühnel, Fabian Tetzlaff, et al.
Page
of 26
Search research articles
Search
Showing results (51-60 of 251) with videos related to
Sort By:
Page
of 26
Frontiers in Oncology
|
April 4, 2019
Novel Approaches to Improve the Efficacy of Immuno-Radiotherapy
Maxim Shevtsov, Hiro Sato, Gabriele Multhoff, et al.
Cell Stress & Chaperones
|
August 31, 2012
Radiosensitization of wildtype p53 cancer cells by the MDM2-inhibitor PXN727 is associated with altered heat shock protein 70 (Hsp70) levels
Daniela Schilling, Michael Düwel, Michael Molls, et al.
Biological Chemistry
|
April 5, 2003
Interaction of heat shock protein 70 peptide with NK cells involves the NK receptor CD94
Catharina Gross, Daniel Hansch, Robert Gastpar, et al.
Journal of Immunological Methods
|
August 2, 2005
Nucleofection of non-B cells with mini-Epstein-Barr virus DNA
Jürgen Radons, Catharina Gross, Stefan Stangl, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 4, 2006
Control of metastasized pancreatic carcinomas in SCID/beige mice with human IL-2/TKD-activated NK cells
Stefan Stangl, Andreas Wortmann, Ulrich Guertler, et al.
Cell Stress & Chaperones
|
March 19, 2008
The therapeutic implications of clinically applied modifiers of heat shock protein 70 (Hsp70) expression by tumor cells
Mathias Gehrmann, Jürgen Radons, Michael Molls, et al.
Cell Stress & Chaperones
|
April 10, 2009
The atheroprotective properties of Hsp70: a role for Hsp70-endothelial interactions?
A Graham Pockley, Stuart K Calderwood, Gabriele Multhoff
Cancer Letters
|
January 22, 2017
The Hsp70 inhibiting peptide aptamer A17 potentiates radiosensitization of tumor cells by Hsp90 inhibition
Daniela Schilling, Carmen Garrido, Stephanie E Combs, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 24, 2005
Alternative mechanism by which IFN-gamma enhances tumor recognition: active release of heat shock protein 72
Maria A Bausero, Robert Gastpar, Gabriele Multhoff, et al.
Cancer Immunology, Immunotherapy : CII
|
April 10, 2015
NZ28-induced inhibition of HSF1, SP1 and NF-κB triggers the loss of the natural killer cell-activating ligands MICA/B on human tumor cells
Daniela Schilling, Annett Kühnel, Fabian Tetzlaff, et al.
Page
of 26